1136 related articles for article (PubMed ID: 25524775)
1. Molecular controls of lymphatic VEGFR3 signaling.
Deng Y; Zhang X; Simons M
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
[TBL] [Abstract][Full Text] [Related]
2. Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3.
Xu Y; Yuan L; Mak J; Pardanaud L; Caunt M; Kasman I; Larrivée B; Del Toro R; Suchting S; Medvinsky A; Silva J; Yang J; Thomas JL; Koch AW; Alitalo K; Eichmann A; Bagri A
J Cell Biol; 2010 Jan; 188(1):115-30. PubMed ID: 20065093
[TBL] [Abstract][Full Text] [Related]
3. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
[TBL] [Abstract][Full Text] [Related]
4. Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells.
Qin TT; Xu GC; Qi JW; Yang GL; Zhang K; Liu HL; Xu LX; Xiang R; Xiao G; Cao H; Wei Y; Zhang QZ; Li LY
J Pathol; 2015 Nov; 237(3):307-18. PubMed ID: 26096340
[TBL] [Abstract][Full Text] [Related]
5. Roles of vascular endothelial growth factor receptor 3 signaling in differentiation of mouse embryonic stem cell-derived vascular progenitor cells into endothelial cells.
Suzuki H; Watabe T; Kato M; Miyazawa K; Miyazono K
Blood; 2005 Mar; 105(6):2372-9. PubMed ID: 15561887
[TBL] [Abstract][Full Text] [Related]
6. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
7. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
Adya R; Tan BK; Punn A; Chen J; Randeva HS
Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
[TBL] [Abstract][Full Text] [Related]
8. Neuropilin-2 mediates lymphangiogenesis of colorectal carcinoma via a VEGFC/VEGFR3 independent signaling.
Ou JJ; Wei X; Peng Y; Zha L; Zhou RB; Shi H; Zhou Q; Liang HJ
Cancer Lett; 2015 Mar; 358(2):200-209. PubMed ID: 25543087
[TBL] [Abstract][Full Text] [Related]
9. VEGFR signaling during lymphatic vascular development: From progenitor cells to functional vessels.
Secker GA; Harvey NL
Dev Dyn; 2015 Mar; 244(3):323-31. PubMed ID: 25399804
[TBL] [Abstract][Full Text] [Related]
10. Pathway-related molecules of VEGFC/D-VEGFR3/NRP2 axis in tumor lymphangiogenesis and lymphatic metastasis.
Wang J; Huang Y; Zhang J; Wei Y; Mahoud S; Bakheet AM; Wang L; Zhou S; Tang J
Clin Chim Acta; 2016 Oct; 461():165-71. PubMed ID: 27527412
[TBL] [Abstract][Full Text] [Related]
11. VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis.
Zhang L; Zhou F; Han W; Shen B; Luo J; Shibuya M; He Y
Cell Res; 2010 Dec; 20(12):1319-31. PubMed ID: 20697430
[TBL] [Abstract][Full Text] [Related]
12. New role for the protein tyrosine phosphatase DEP-1 in Akt activation and endothelial cell survival.
Chabot C; Spring K; Gratton JP; Elchebly M; Royal I
Mol Cell Biol; 2009 Jan; 29(1):241-53. PubMed ID: 18936167
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor-C promotes human mesenchymal stem cell migration via an ERK-and FAK-dependent mechanism.
Ishii M; Takahashi M; Murakami J; Yanagisawa T; Nishimura M
Mol Cell Biochem; 2019 May; 455(1-2):185-193. PubMed ID: 30443854
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of Akt and ERK1/2 is required for VEGF-A/VEGFR2-induced proliferation and migration of lymphatic endothelium.
Dellinger MT; Brekken RA
PLoS One; 2011; 6(12):e28947. PubMed ID: 22174934
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor-C induces osteogenic differentiation of human mesenchymal stem cells through the ERK and RUNX2 pathway.
Murakami J; Ishii M; Suehiro F; Ishihata K; Nakamura N; Nishimura M
Biochem Biophys Res Commun; 2017 Mar; 484(3):710-718. PubMed ID: 28163024
[TBL] [Abstract][Full Text] [Related]
16. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
17. Curcumin inhibits lymphangiogenesis in vitro and in vivo.
Wang W; Sukamtoh E; Xiao H; Zhang G
Mol Nutr Food Res; 2015 Dec; 59(12):2345-54. PubMed ID: 26375757
[TBL] [Abstract][Full Text] [Related]
18. Essential role of Apelin signaling during lymphatic development in zebrafish.
Kim JD; Kang Y; Kim J; Papangeli I; Kang H; Wu J; Park H; Nadelmann E; Rockson SG; Chun HJ; Jin SW
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):338-45. PubMed ID: 24311379
[TBL] [Abstract][Full Text] [Related]
19. Total saponins of panaxnotoginseng promotes lymphangiogenesis by activation VEGF-C expression of lymphatic endothelial cells.
Li J; Chen Y; Zhang L; Xing L; Xu H; Wang Y; Shi Q; Liang Q
J Ethnopharmacol; 2016 Dec; 193():293-302. PubMed ID: 27553977
[TBL] [Abstract][Full Text] [Related]
20. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.
Wang Y; Nakayama M; Pitulescu ME; Schmidt TS; Bochenek ML; Sakakibara A; Adams S; Davy A; Deutsch U; Lüthi U; Barberis A; Benjamin LE; Mäkinen T; Nobes CD; Adams RH
Nature; 2010 May; 465(7297):483-6. PubMed ID: 20445537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
